| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S40266-018-0597-4 |
| P698 | PubMed publication ID | 30411283 |
| P50 | author | Shelly A McNeil | Q56433319 |
| George Kuchel | Q77067218 | ||
| Melissa K Andrew | Q90136389 | ||
| Janet E McElhaney | Q92876176 | ||
| Graham Pawelec | Q37369975 | ||
| Susan K Bowles | Q45294780 | ||
| P2093 | author name string | Laura Haynes | |
| P2860 | cites work | Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis | Q28067038 |
| Influenza vaccination in the elderly: impact on hospitalisation and mortality. | Q30350930 | ||
| Cellular immune correlates of protection against symptomatic pandemic influenza. | Q30353819 | ||
| Pre- and postpandemic estimates of 2009 pandemic influenza A(H1N1) seroprotection to inform surveillance-based incidence, by age, during the 2013-2014 epidemic in Canada. | Q30364076 | ||
| Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. | Q30399272 | ||
| Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis | Q30891396 | ||
| Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial | Q30993108 | ||
| Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults | Q33567685 | ||
| Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents | Q33760887 | ||
| Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals | Q33870216 | ||
| Frailty in elderly people | Q33902569 | ||
| Clinical and immunologic predictors of influenza illness among vaccinated older adults | Q34170212 | ||
| Efficacy of high-dose versus standard-dose influenza vaccine in older adults | Q34433416 | ||
| Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012. | Q35794869 | ||
| Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review | Q35887679 | ||
| The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People | Q57792424 | ||
| Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines | Q74145632 | ||
| Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly | Q77436729 | ||
| T cell responses are better correlates of vaccine protection in the elderly | Q83276474 | ||
| EXamining the knowledge, Attitudes and experiences of Canadian seniors Towards influenza (the EXACT survey) | Q93050110 | ||
| Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis | Q36353907 | ||
| The confounded effects of age and exposure history in response to influenza vaccination | Q36495901 | ||
| Role of T lymphocyte replicative senescence in vaccine efficacy | Q36610085 | ||
| Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans | Q36658296 | ||
| Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States | Q36957563 | ||
| Aging of the immune system as a prognostic factor for human longevity | Q37133613 | ||
| Immunosenescence: what does it mean to health outcomes in older adults? | Q37301037 | ||
| Th1 and Th2 responses: what are they? | Q37350671 | ||
| Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response | Q37461377 | ||
| High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors | Q37560859 | ||
| Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe | Q37660781 | ||
| Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015. | Q38406947 | ||
| Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics | Q38632048 | ||
| Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial. | Q38665894 | ||
| Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups | Q38835739 | ||
| Comparison of influenza vaccination coverage between immigrant and Australian-born adults | Q39290539 | ||
| Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season | Q40070473 | ||
| Influenza and Workplace Productivity Loss in Working Adults. | Q40101305 | ||
| Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013. | Q40146222 | ||
| Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older | Q40151067 | ||
| Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014. | Q40280177 | ||
| Randomized comparison of the safety of Flublok(®) versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥ 50 years of age. | Q41154949 | ||
| Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage | Q41928464 | ||
| Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies | Q41932605 | ||
| Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada | Q41932798 | ||
| Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap | Q44063966 | ||
| A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis | Q44392994 | ||
| Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly | Q45286357 | ||
| Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy | Q46623415 | ||
| Estimates of global seasonal influenza-associated respiratory mortality: a modelling study | Q46876629 | ||
| Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. | Q46930331 | ||
| Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada | Q47137946 | ||
| Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons | Q47678684 | ||
| Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network. | Q48065467 | ||
| Relative Vaccine Effectiveness of High-Dose versus Standard-Dose Influenza Vaccines among Veterans Health Administration Patients. | Q49922626 | ||
| Influenza burden in frail elderly | Q50174081 | ||
| Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Seriou | Q52651633 | ||
| Effective Immunization of Older Adults Against Seasonal Influenza. | Q54255217 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 29-37 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Drugs & Aging | Q5308946 |
| P1476 | title | Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications | |
| P478 | volume | 36 |
| Q94587487 | Archetype analysis of older adult immunization decision-making and implementation in 34 countries |
| Q90140265 | Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults |
| Q99592761 | Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective |
| Q94602411 | Recent advances in influenza vaccines |
| Q98497953 | Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19 |
| Q94545406 | Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives |
Search more.